Delivery Order SPE2DB22D2009-SPE2DB24FL8TJ
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $3,437.38 award is for the delivery of 4,564,161,295 units of the pharmaceutical product NURTEC ODT 75 MG TABLET, with an ultimate completion date of April 4, 2024. The delivery order was issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,564,096,545 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S, with a ceiling value of $34,866.47 and a performance period through March 28, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,118,646 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract has a ceiling value of $39,263.29 and a performance period through April 1, 2024. This delivery order was issued under an existing Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $52,187.93, is for the supply of 4,567,968,298 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a $1,124.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,307,712 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The ultimate completion date for the contract is August 1, 2024. This award is not associated with any set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
- This is a $4,032.77 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565232062 NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through July 24, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,185,885 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The $9,554.11 contract has a completion date of December 28, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and related distribution services to DLA Troop Support Medical...
- This is a delivery order award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,842.36 firm fixed price award is for the supply of the prescription medication NURTEC ODT 75 MG TABLET 8S. The delivery order has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corporation holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,563,982,080 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The delivery order has a ceiling value of $16,096.29 and a performance period through March 18, 2024. This order is placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,568,188,781 units of the drug NURTEC ODT 75 MG TABLET 8S, with a ceiling value of $24,958.38. The contract is a firm fixed-price, non-set-aside delivery order with a period of performance through May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL8TJDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $4,082.46 order is for 4,564,002,442 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The award has a performance period through March 19, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 3/18/24 |